Where is the manufacturer located?

The company is located in Guangzhou, Guangdong, China.

What are the main markets for this product?

The main market is currently domestic.

Dog Ehrlichia/Anaplasma Antibody Combo Rapid Test Ehr-Ana Ab

Name: Dog Ehrlichia/Anaplasma Antibody Combo Rapid Test Ehr-Ana Ab
Brand: Guangzhou Herun Bio-Pharm Co., Ltd.
SKU: 2173179035

Guangdong, ChinaGuangzhou Herun Bio-Pharm Co., Ltd.

US$1.00-2.00

100 Pieces

Product profile

Customization

Available

Type

Detection Card

Syringe

Test Kit

Model NO.

HA-022

Blood Sampling Needle

Test Kit

Breathing Pattern

Test Kit

Animal Anesthesia Machine Control Method

Test Kit

Package

10t/20t/Box

Warranty

12 Months

Animals

Dog

Transport Package

Carton

Specification

1PC/Aluminum Foil Bag, 20PCS/Box.

Trademark

CHEMICOS

Origin

Guangzhou, China

HS Code

38220090

Production Capacity

100000 Pieces/Day

Key features

12 Months Warranty: Comprehensive 12-month warranty coverage for peace of mind.

Easy Result Interpretation: Clear, easy-to-read outcomes for quick and confident decision-making.

High Accuracy & Reliability: Cutting-edge technology ensures precise and reliable test results.

OEM/ODM Support: Customization services available for packaging and branding needs.

Low MOQ: Minimum Order Quantity starts at just 1 piece for flexibility.

Company profile

Exhibition ExperienceLow MOQCustomization from SamplesODM Services

Guangzhou Herun Bio-Pharm Co., Ltd.

Guangdong, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedExport Year: N/A CertifiedNearest Port: Guangzhou Port, Shenzhen PortAverage Response Time: ≤9.86h CertifiedTerms of Payment: T/T

AI-Powered supplier vetting

SummaryThe supplier operates across services, forestry, animal husbandry and fishery, medical research, and sales of specialized medical, optical, agricultural, and testing equipment. It provides 3D design, ODM, OEM, SDK, and multiple customization services. Documented procedures exist for supplier assessment, corrective and preventive actions, and complaint handling, but quality assurance and raw-material traceability statuses are unknown. The supplier reports no new products in the past year and no inventory, overseas warehouse, or overseas showroom capability. Financial records are indicated for 2021–2023, but the provided data does not disclose performance results. Its company description emphasizes diagnostic products, protein-expression technology, R&D investment, and collaboration with universities and institutions.

Supplier typeThe supplier is a diversified service and technology-oriented company covering agricultural, forestry, animal husbandry and fishery, medical research, and specialized instrument and medical-device sales. Its stated focus on diagnostic products and solutions for human and animal health further indicates a life-science and healthcare-related supplier profile.

After-Sales capabilityThe supplier has a clear, documented complaint-handling procedure with implementation records and documented service-capability assessment procedures. However, no specific response scope, service network, or after-sales performance information is provided.

R&D capabilityThe supplier provides ODM services, OEM services for well-known brands, an available SDK, 3D design, and multiple design-customization options. Its description also cites product-development technology platforms, R&D investment, experienced scientists, and university or institutional collaboration; however, it launched no new products during the past year.

Customization capabilityThe supplier explicitly supports customization from samples, customization from designs, and full customization, along with 3D software design and ODM services. These statements provide direct evidence of broad product and design customization capability.